ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,292.86
-0.08%
Dow Jones
39,917.62
0.12%
US Dollar vs MXN
16.6067
-0.44%
Brent Oil
83.735
0.64%
Bitcoin
66,387.63
1.76%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Arrowhead Pharmaceuticals Inc (ARWR)

  7. Arrowhead Pharmaceuticals Inc (ARWR) Noticias

ARWR

Arrowhead Pharmaceuticals (ARWR)

Arrowhead Pharmaceuticals Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:ARWR
FechaHoraFuenteTítuloSímboloCompañía
09/05/202415:11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ARWRArrowhead Pharmaceuticals Inc
06/05/202417:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARWRArrowhead Pharmaceuticals Inc
16/04/202408:00GlobeNewswire Inc.Turnstone Biologics Appoints William Waddill to its Board of DirectorsNASDAQ:ARWRArrowhead Pharmaceuticals Inc
06/03/202416:30Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ARWRArrowhead Pharmaceuticals Inc
27/02/202416:08Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ARWRArrowhead Pharmaceuticals Inc
06/02/202415:13Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ARWRArrowhead Pharmaceuticals Inc
17/01/202416:22Edgar (US Regulatory)Form 144/A - Report of proposed sale of securities: [Amend]NASDAQ:ARWRArrowhead Pharmaceuticals Inc
04/01/202416:01Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ARWRArrowhead Pharmaceuticals Inc
29/11/202315:09Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:ARWRArrowhead Pharmaceuticals Inc
27/06/202315:02Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:ARWRArrowhead Pharmaceuticals Inc
09/06/202313:17Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ARWRArrowhead Pharmaceuticals Inc
05/05/202318:05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARWRArrowhead Pharmaceuticals Inc
21/03/202305:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ARWRArrowhead Pharmaceuticals Inc
12/02/202310:30ValueWalkHere Are The Five Best- And Worst-Performing Mid-Cap Stocks In Jan. 2023NASDAQ:ARWRArrowhead Pharmaceuticals Inc
11/02/202309:22ValueWalkAshSwap the first stable-swap DEX Launches on MultiversX MainnetNASDAQ:ARWRArrowhead Pharmaceuticals Inc
06/02/202315:03Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ARWRArrowhead Pharmaceuticals Inc
30/01/202315:47Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ARWRArrowhead Pharmaceuticals Inc
20/01/202308:46Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ARWRArrowhead Pharmaceuticals Inc
05/12/202205:04Edgar (US Regulatory)Automatic Shelf Registration Statement of Securities of Well-known Seasoned Issuers (s-3asr)NASDAQ:ARWRArrowhead Pharmaceuticals Inc
30/11/202206:35TipRanksArrowhead Pharmaceuticals (ARWR) Gets a Buy from B.Riley FinancialNASDAQ:ARWRArrowhead Pharmaceuticals Inc
29/11/202222:15TipRanksRobert W. Baird Remains a Buy on Arrowhead Pharmaceuticals (ARWR)NASDAQ:ARWRArrowhead Pharmaceuticals Inc
29/11/202214:25TipRanksArrowhead Pharmaceuticals (ARWR) Receives a Buy from JefferiesNASDAQ:ARWRArrowhead Pharmaceuticals Inc
29/11/202210:25TipRanksMorgan Stanley Remains a Hold on Arrowhead Pharmaceuticals (ARWR)NASDAQ:ARWRArrowhead Pharmaceuticals Inc
29/11/202207:50TipRanksAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Arrowhead Pharmaceuticals (ARWR) and Boston Scientific (BSX)NASDAQ:ARWRArrowhead Pharmaceuticals Inc
10/11/202208:05TipRanksB.Riley Financial Sticks to Its Buy Rating for Arrowhead Pharmaceuticals (ARWR)NASDAQ:ARWRArrowhead Pharmaceuticals Inc
10/11/202206:36TipRanksArrowhead Pharmaceuticals (ARWR) Gets a Hold from SVB SecuritiesNASDAQ:ARWRArrowhead Pharmaceuticals Inc
09/11/202222:27TipRanksSVB Securities Sticks to Their Hold Rating for Arrowhead Pharmaceuticals (ARWR)NASDAQ:ARWRArrowhead Pharmaceuticals Inc
05/11/202216:58TipRanksArrowhead to hold virtual analyst and investor eventNASDAQ:ARWRArrowhead Pharmaceuticals Inc
14/10/202206:15TipRanksArrowhead Pharmaceuticals (ARWR) Receives a Buy from B.Riley FinancialNASDAQ:ARWRArrowhead Pharmaceuticals Inc
30/09/202216:33Edgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)NASDAQ:ARWRArrowhead Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:ARWR

Su Consulta Reciente

NYSE
DIS
Walt Disney
USOTC
ADDYY
Adidas (QX)
NASDAQ
GOOGL
Alphabet
CCOM
OILBRENT
Brent Oil
COIN
ETHUSD
Ethereum
USOTC
BNPQY
BNP Paribas (QX)
SPI
SP500
S&P 500
NASDAQ
TSLA
Tesla
NYSE
MRK
Merck
NYSE
BAC
Bank of America
NASDAQ
NVDA
NVIDIA
FX
USDMXN
US Dollar vs MXN
USI
USTECH100
US Tech 100
NYSE
JPM
JP Morgan Chase
COIN
SOLUSD
Solana
FX
EURMXN
Euro vs MXN
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados